Jasper Therapeutics, Inc. announced that four abstracts highlighting the clinical progress of briquilimab, an antibody therapy targeting c-Kit for mast cell-driven diseases, will be presented at the ...
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that more than 40 abstracts highlighting data from eight of its hematology and oncology products will be presented at the ...
Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced the acceptance of multiple abstracts for presentation at three significant upcoming congresses focusing on angioedema, ...
Oral presentation of investigator-initiated Phase 2 study evaluating ZYNLONTA ® (loncastuximab tesirine-lpyl) in combination with rituximab in patients with r/r follicular lymphoma Poster presentation ...
HerResolve™ first and only assay validated against ground truth of laparoscopy with confirmed histology. Company to Exhibit at Booth #4 BOSTON, MA, UNITED STATES ...
Generation of a Concise Gene Panel for Outcome Prediction in Urinary Bladder Cancer We identified 138 consecutive reports of RCTs testing systemic therapy for lymphoma, breast, colorectal, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results